Back

Pre-transplant TCR Network Topology Predicts Kidney Allograft Rejection Independent of HLA Mismatch

Borcherding, N.; Sanders, J. M.; Martens, G. R.; Murakami, N.; Doilicho, N.; Banbury, B. L.; He, J.; Leventhal, J. R.; Mathew, J. M.

2026-05-07 immunology
10.64898/2026.05.04.722749 bioRxiv
Show abstract

Despite extensive pretransplant serological screening and HLA matching, 10-15% of kidney allografts experience acute rejection within the first year. Currently, risk stratification for transplantation relies primarily on antibody reactivity to HLA molecules, with no assessment of the T cell compartment before or after transplantation. In our previously established longitudinal cohort of 54 patients, T cell receptor {beta} (TCR{beta}) sequencing was performed on paired kidney biopsy and peripheral blood samples. Here, we further analyzed the data to construct a comprehensive set of sequence-similarity networks and quantify over 30 network metrics. After adjusting for repertoire size, graft status was the strongest signal for the underlying differences in network metrics. Individuals who rejected the kidney graft generally exhibited more fragmented and less connected networks at baseline, with fewer interconnect T cell clones and more isolated sequences. Notably, pre-transplant peripheral blood mononuclear cell (PBMC) network topology alone predicted non-stable outcomes with an area under the curve (AUC) of 0.81, sensitivity of 76%, and specificity of 76%. The performance of this prediction model was independent of HLA mismatch, while changes in network topology at three months post-transplantation further improved prediction to an AUC of 0.88 (permutation p = 0.009). Collectively, TCR sequencing and network analysis represent a potential novel, non-invasive approach for pre-transplant risk stratification and immune monitoring, capturing functional immunological risk that may not be accessible through HLA genotyping or serology.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
Nature Immunology
71 papers in training set
Top 0.1%
8.3%
2
Transplantation
13 papers in training set
Top 0.1%
8.3%
3
American Journal of Transplantation
15 papers in training set
Top 0.1%
6.2%
4
eLife
5422 papers in training set
Top 18%
4.8%
5
Nature Communications
4913 papers in training set
Top 34%
4.8%
6
JCI Insight
241 papers in training set
Top 0.8%
4.8%
7
Immunity
58 papers in training set
Top 1%
3.5%
8
Science Translational Medicine
111 papers in training set
Top 1.0%
3.5%
9
Frontiers in Immunology
586 papers in training set
Top 2%
3.5%
10
Cell Reports
1338 papers in training set
Top 17%
3.0%
50% of probability mass above
11
Journal of Clinical Investigation
164 papers in training set
Top 1%
3.0%
12
Cell Reports Medicine
140 papers in training set
Top 2%
2.6%
13
Journal of Experimental Medicine
106 papers in training set
Top 1%
2.3%
14
Genome Medicine
154 papers in training set
Top 4%
1.9%
15
Nature Medicine
117 papers in training set
Top 2%
1.9%
16
Science Advances
1098 papers in training set
Top 16%
1.8%
17
The Journal of Heart and Lung Transplantation
10 papers in training set
Top 0.2%
1.7%
18
Scientific Reports
3102 papers in training set
Top 59%
1.7%
19
Journal for ImmunoTherapy of Cancer
64 papers in training set
Top 0.6%
1.6%
20
Circulation
66 papers in training set
Top 2%
1.6%
21
Molecular Therapy
71 papers in training set
Top 2%
1.3%
22
Communications Biology
886 papers in training set
Top 13%
1.3%
23
npj Vaccines
62 papers in training set
Top 0.3%
1.2%
24
Kidney International Reports
14 papers in training set
Top 0.2%
1.1%
25
Blood
67 papers in training set
Top 1%
0.9%
26
Stem Cell Reports
118 papers in training set
Top 0.7%
0.9%
27
iScience
1063 papers in training set
Top 30%
0.8%
28
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 43%
0.8%
29
eBioMedicine
130 papers in training set
Top 4%
0.8%
30
Blood Advances
54 papers in training set
Top 1%
0.8%